WO2003026715A2 - Monolayer modification to gold coated stents to reduce adsorption of protein - Google Patents
Monolayer modification to gold coated stents to reduce adsorption of protein Download PDFInfo
- Publication number
- WO2003026715A2 WO2003026715A2 PCT/US2001/049788 US0149788W WO03026715A2 WO 2003026715 A2 WO2003026715 A2 WO 2003026715A2 US 0149788 W US0149788 W US 0149788W WO 03026715 A2 WO03026715 A2 WO 03026715A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- coating
- medical device
- metal
- intraluminal medical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
- A61L31/088—Other specific inorganic materials not covered by A61L31/084 or A61L31/086
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
Definitions
- noble metal shall refer to a metal of the group Ruthenium (Ru), Rhodium (Rd), Palladium (Pd), Osmium (Os), Iridium (Ir), Platinum (Pt), Silver (Ag), and Gold (Au).
- the instant invention is directed in at least some of its embodiments to coated stents.
- Other embodiments of the invention include methods of coating stents.
- the invention is directed to a stent having a body and a surface, at least a portion of the surface comprising a metal with a coating on the metal.
- the coating is selected from the group consisting of thiols and disulfides and combinations thereof.
- the thiols are of the form R-SH and the disulfides are of the form R-S-S-R" where R and R" are alkyl groups.
- R has at least 4 carbons. Desirably, R has from 1 2 carbons to 32 carbons. More desirably R has from 1 2 to 24 carbons. Suitably, R" has at least 4 carbons. Desirably, R" has from 1 2 carbons to 32 carbons.
- R" has from 1 2 to 24 carbons.
- Only a portion of the surface may be metal or, more desirably, the entirety of the surface may comprise the metal.
- the metal desirably is selected from the group consisting of noble metals, copper and silver and combinations thereof. Where the metal is gold, the gold may be coated on the body of the stent via plating or any other technique. Desirably, the thiol and/or disulfide coating is substantially one monolayer thick.
- the invention is also directed to a method of preparing a stent comprising the steps of providing a stent having a surface at least a portion of which is metal and coating the metal surface with a coating moiety selected from the group consisting of thiols and disulfides and combinations thereof.
- the thiols are of the form R-SH and the disulfides are of the form R-S-S-R" where R is an alkyl group and R" is an alkyl group.
- R has at least 4 carbons. Desirably, R has from 1 2 carbons to 32 carbons. More desirably R has from 1 2 to 24 carbons. Suitably, R" has at least 4 carbons.
- R" has from 12 carbons to 32 carbons. More desirably R" has from 12 to 24 carbons. Desirably, the entire surface of the stent is coated in the coating step. Also desirably, the metal is selected from the group consisting of noble metals, copper and silver. More desirably, the metal is gold.
- the coating moiety may be disposed in a solvent such as methanol, ethanol, isopropanol and combinations thereof and the stent placed in the solvent. The coating may be provided via other techniques as well including spraying the coating on the metal surface of the stent. Desirably, the coating is substantially one monolayer thick.
- the invention is also directed to a stent at least a portion of which has a substantially monolayer thick coating of one or more members selected from the group consisting of thiols, disulfides, and combinations thereof.
- a stent at least a portion of which has a substantially monolayer thick coating of one or more members selected from the group consisting of thiols, disulfides, and combinations thereof.
- at least a portion of the stent includes a layer of gold thereon, the monolayer coating disposed on the layer of gold. More desirably, the gold layer and monolayer coating extend over the entirety of the surface of the body portion of the stent.
- FIG. 1 shows a perspective view of an inventive stent
- FIG. 2 shows a cross-sectional view of the stent of Fig. 1 taken along line 2-
- FIG. 3 shows a perspective view of another inventive stent
- FIG. 4 shows a perspective view of another inventive stent.
- the instant invention is directed in at least some of its embodiments to coated stents.
- Other embodiments of the invention include methods of coating stents.
- the inventive stent may be any suitable stent having a surface at least a portion of which comprises metal with an inventive coating thereon.
- An example of a stent is shown in Fig. 1 at 100.
- Stent 100 comprises a plurality of serpentine segments 104, each of which comprises a plurality of interconnected struts 107. Segments 104, which are adjacent one another are connected together via connectors 108. As shown in Fig. 1 , connectors 108 have at one bend therein.
- the connectors may also be provided with a plurality of bends or may substantially linear or rectilinear.
- the instant invention may be practiced using a stent such as that shown in Fig. 1 or using any other stent geometry.
- Stent 1 00 is shown in transverse cross-section in Fig. 2.
- the stent includes body 1 1 2 and surface 1 1 6 as shown in Fig. 2. At least a portion and desirably, the entirety, of surface 1 16 comprises a metal such as a noble metal, copper, silver or another radiopaque metal. Desirably, the metal is gold.
- the body of the stent may also comprise the metal or may comprise one or more different metals or polymeric materials. Other suitable metals for the body of the stent include 316L stainless steel, chromium, nickel, titanium, or iridium, or nitinol.
- the gold or other surface metal may be coated on the body of the stent by plating, painting, swaging, vapor deposition or may be otherwise deposited on the body of the stent. Coating of stents with metals such as gold is discussed in commonly assigned US Application 09/659571 as well as in US 5,824,045. As shown in Figs. 1 and 2, the metal surface of the inventive stents has a coating 120 thereon selected from the group consisting of thiols and disulfides and combinations thereof. The coating is indicated by hatching in Fig. 1 .
- the thiols are of the form R-SH and the disulfides are of the form R- S-S-R" where R is an alkyl group and R" is an alkyl group.
- R has at least 4 carbons. Desirably, R has from 1 2 carbons to 32 carbons. More desirably R has from 1 2 to 24 carbons.
- R" has at least 4 carbons. Desirably, R" has from 1 2 carbons to 32 carbons. More desirably R" has from 12 to 24 carbons.
- the alkyl group R and/or R" is a 1 6 carbon alkyl group.
- the alkyl group is a straight chain alkyl group.
- the thiol and/or disulfide coating is substantially one monolayer thick and in the form of a self-arranging monolayer.
- the invention is also directed to a stent at least a portion of which has a substantially monolayer thick coating of one or more members selected from the group consisting of thiols, disulfides, and combinations thereof.
- a stent at least a portion of which has a substantially monolayer thick coating of one or more members selected from the group consisting of thiols, disulfides, and combinations thereof.
- at least a portion of the stent includes a layer of gold thereon, the monolayer coating disposed on the layer of gold. More desirably, the gold layer and monolayer coating extend over the entirety of the surface of the body portion of the stent.
- Stent 100 of Fig. 3 includes a plurality of serpentine segments 104. Each serpentine segment comprises a plurality of interconnected struts 107. Adjacent serpentine segments 104 are connected by substantially linear connectors 108 extending therebetween.
- Proximal end 101 and distal end 102 include a surface layer of metal such as gold. The surface layer is coated with a coating comprising a thiol, disulfide, or both as discussed above. The coating is indicated by hatching in the figure.
- FIG. 4 Yet another example of such a stent is shown generally at 100 in Fig. 4.
- Stent 100 includes bands of metals such as noble metals, or silver which are coated with a coating 120 comprising a thiol, disulfide, or both as discussed above.
- stents having any other pattern of noble metals, copper and/or silver on the surface of the stent.
- the coating is desirably limited to the patterned metal. Examples of other specific patterns are shown in US application No. 09/697634.
- the invention is also directed to methods of preparing a stent comprising the steps of providing a stent having a surface at least a portion of which comprises metal and coating at least a portion of the metal with a coating moiety selected from the group consisting of thiols and disulfides and combinations thereof.
- the metal is desirably a radiopaque metal. Suitable metals include noble metals, copper and silver.
- the body of the stent may be formed of the same metal as that on the surface of the stent or may be made of a different metal or material. As an example, where the surface metal is a layer of gold, the gold may be providing by plating, painting, swaging, vapor deposition or otherwise depositing it.
- the thiols are of the form R-SH and the disulfides are of the form R-S-S-R" where R is an alkyl group and R" is an alkyl group.
- R has at least 4 carbons. Desirably, R has from 1 2 carbons to 32 carbons. More desirably R has from 1 2 to 24 carbons.
- R" has at least 4 carbons. Desirably, R" has from 1 2 carbons to 32 carbons. More desirably R" has from 1 2 to 24 carbons.
- the alkyl group R and/or R" is a 1 6 carbon alkyl group.
- the alkyl group is a straight chain alkyl group.
- the coating moiety may be applied to the surface metal through any suitable technique.
- One suitable method involves providing the coating moiety in a solvent.
- Suitable solvents include methanol, ethanol and isopropanol.
- the concentration of the coating moiety in the solvent is between about 0.1 mM (millimolar) and 10 mM.
- the stent may be dipped in the solvent or the solvent sprayed on the stent. In the former case, using the concentrations disclosed above, the stent is desirably dipped in the solvent for a period of from about 0.5 hour to about 24 hours.
- the coating moiety desirably forms a self-arranging monolayer on the metal surface.
- the concentration of the coating moiety is desirably significantly greater than the above-mentioned values to facilitate the formation of a self-arranging monolayer on the stent.
- the stent may be removed from the solvent or spraying of the stent ceased and the stent allowed to dry.
- the noble metal, silver or copper may selectively be coated by masking those portions of the stent which do not have the metal thereon so that only the relevant portions of the stent are exposed for coating.
- the invention is also directed to stents made using any of the inventive techniques disclosed herein.
- the inventive stents may be used for coronary arteries, peripheral arteries, arteries of the neck and intracranial arteries. More generally, the inventive stents may be used for any vessel of the human body including but not limited to arteries, veins, biliary ducts, urethras, fallopian tubes, bronchial tubes, the trachea and the esophagus.
- Suitable stent delivery devices including those disclosed in US 6,123,712, US
- 6,120,522 and US 5,957,930 may be used to deliver the inventive stents to the desired bodily location.
- the choice of delivery device will depend on whether a self-expanding or balloon expandable stent is used.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01989249A EP1387704B1 (en) | 2000-12-26 | 2001-12-18 | Monolayer modification to gold coated stents to reduce adsorption of protein |
DE60139083T DE60139083D1 (en) | 2000-12-26 | 2001-12-18 | OSAGE TO REDUCE PROTEIN ADSORPTION |
AT01989249T ATE434453T1 (en) | 2000-12-26 | 2001-12-18 | MODIFICATION OF GOLD-COATED STENTS WITH MONOLAYERS TO REDUCE PROTEIN ADSORPTION |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/681,080 US6398806B1 (en) | 2000-12-26 | 2000-12-26 | Monolayer modification to gold coated stents to reduce adsorption of protein |
US09/681,080 | 2000-12-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003026715A2 true WO2003026715A2 (en) | 2003-04-03 |
WO2003026715A3 WO2003026715A3 (en) | 2003-12-04 |
Family
ID=24733725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/049788 WO2003026715A2 (en) | 2000-12-26 | 2001-12-18 | Monolayer modification to gold coated stents to reduce adsorption of protein |
Country Status (6)
Country | Link |
---|---|
US (2) | US6398806B1 (en) |
EP (1) | EP1387704B1 (en) |
AT (1) | ATE434453T1 (en) |
DE (1) | DE60139083D1 (en) |
ES (1) | ES2329113T3 (en) |
WO (1) | WO2003026715A2 (en) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1289815B1 (en) * | 1996-12-30 | 1998-10-16 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS |
US20040267350A1 (en) * | 2002-10-30 | 2004-12-30 | Roubin Gary S. | Non-foreshortening intraluminal prosthesis |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US20010047200A1 (en) | 1999-10-13 | 2001-11-29 | Raymond Sun | Non-foreshortening intraluminal prosthesis |
EP1229901B1 (en) * | 1999-11-17 | 2009-03-18 | Boston Scientific Limited | Microfabricated devices for the delivery of molecules into a carrier fluid |
US20050203612A1 (en) * | 2000-12-22 | 2005-09-15 | Avantec Vascular Corporation | Devices delivering therapeutic agents and methods regarding the same |
US6569194B1 (en) | 2000-12-28 | 2003-05-27 | Advanced Cardiovascular Systems, Inc. | Thermoelastic and superelastic Ni-Ti-W alloy |
US7727221B2 (en) | 2001-06-27 | 2010-06-01 | Cardiac Pacemakers Inc. | Method and device for electrochemical formation of therapeutic species in vivo |
US6656216B1 (en) | 2001-06-29 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Composite stent with regioselective material |
DE60120955T3 (en) * | 2001-07-20 | 2015-06-25 | Cid S.P.A. | stent |
WO2003009779A2 (en) * | 2001-07-26 | 2003-02-06 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
US20050178584A1 (en) * | 2002-01-22 | 2005-08-18 | Xingwu Wang | Coated stent and MR imaging thereof |
DE10317241A1 (en) | 2003-04-10 | 2004-10-28 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | stent |
US7479158B2 (en) * | 2004-02-20 | 2009-01-20 | Boston Scientific Scimed, Inc. | Stent with nested flexible connectors for flexibility and crimpability |
US20060025848A1 (en) * | 2004-07-29 | 2006-02-02 | Jan Weber | Medical device having a coating layer with structural elements therein and method of making the same |
EP1789107B1 (en) | 2004-08-30 | 2009-05-27 | Interstitial Therapeutics | Medical stent provided with inhibitors of atp synthesis |
CA2577108A1 (en) | 2004-08-31 | 2006-03-09 | C.R. Bard, Inc. | Self-sealing ptfe graft with kink resistance |
KR20070095916A (en) * | 2004-11-26 | 2007-10-01 | 스텐토믹스 인코포레이티드 | Chelating and binding chemicals to a medical implant |
EP1887968A4 (en) * | 2005-06-08 | 2013-01-23 | Bard Inc C R | Grafts and stents having inorganic bio-compatible calcium salt |
WO2007001472A2 (en) | 2005-06-17 | 2007-01-04 | C. R. Bard, Inc. | Vascular graft with kink resistance after clamping |
JP5118042B2 (en) * | 2005-09-06 | 2013-01-16 | シー・アール・バード・インコーポレーテッド | Implant for transplantation containing drug crystals |
US20080188793A1 (en) * | 2007-02-06 | 2008-08-07 | Possis Medical, Inc. | Miniature flexible thrombectomy catheter |
US8012117B2 (en) * | 2007-02-06 | 2011-09-06 | Medrad, Inc. | Miniature flexible thrombectomy catheter |
WO2007056761A2 (en) | 2005-11-09 | 2007-05-18 | C.R. Bard Inc. | Grafts and stent grafts having a radiopaque marker |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
JP2009542359A (en) | 2006-06-29 | 2009-12-03 | ボストン サイエンティフィック リミテッド | Medical device with selective covering |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
EP2068757B1 (en) | 2006-09-14 | 2011-05-11 | Boston Scientific Limited | Medical devices with drug-eluting coating |
JP2010503491A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Bioerodible endoprosthesis with biologically stable inorganic layers |
EP2081616B1 (en) | 2006-09-15 | 2017-11-01 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
EP2068782B1 (en) | 2006-09-15 | 2011-07-27 | Boston Scientific Limited | Bioerodible endoprostheses |
CA2663220A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
WO2008063780A2 (en) | 2006-10-12 | 2008-05-29 | C.R. Bard Inc. | Vascular grafts with multiple channels and methods for making |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
DE602007010669D1 (en) | 2006-12-28 | 2010-12-30 | Boston Scient Ltd | HREN FOR THIS |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
KR101023164B1 (en) * | 2007-06-19 | 2011-03-18 | (주)바이오니아 | Gold-coated stent coated/plated the chemicals and oligonucleotide binding gold-coated stent and process for producing the same |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
JP2010533563A (en) | 2007-07-19 | 2010-10-28 | ボストン サイエンティフィック リミテッド | Endoprosthesis with adsorption inhibiting surface |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US20090104434A1 (en) * | 2007-10-17 | 2009-04-23 | Jennifer Hoyt Lalli | Conformal multifunctional coatings |
US8142490B2 (en) * | 2007-10-24 | 2012-03-27 | Cordis Corporation | Stent segments axially connected by thin film |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
WO2010101901A2 (en) | 2009-03-02 | 2010-09-10 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824045A (en) | 1996-10-21 | 1998-10-20 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US5957930A (en) | 1996-09-27 | 1999-09-28 | Scimed Life Systems, Inc. | Stent deployment catheter with midshaft seal |
US6120522A (en) | 1998-08-27 | 2000-09-19 | Scimed Life Systems, Inc. | Self-expanding stent delivery catheter |
US6123712A (en) | 1996-08-23 | 2000-09-26 | Scimed Life Systems, Inc. | Balloon catheter with stent securement means |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059166A (en) * | 1989-12-11 | 1991-10-22 | Medical Innovative Technologies R & D Limited Partnership | Intra-arterial stent with the capability to inhibit intimal hyperplasia |
US6255277B1 (en) | 1993-09-17 | 2001-07-03 | Brigham And Women's Hospital | Localized use of nitric oxide-adducts to prevent internal tissue damage |
US6087479A (en) | 1993-09-17 | 2000-07-11 | Nitromed, Inc. | Localized use of nitric oxide-adducts to prevent internal tissue damage |
US5770645A (en) * | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US6232434B1 (en) * | 1996-08-02 | 2001-05-15 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US6174329B1 (en) | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
US6174326B1 (en) | 1996-09-25 | 2001-01-16 | Terumo Kabushiki Kaisha | Radiopaque, antithrombogenic stent and method for its production |
US6099561A (en) | 1996-10-21 | 2000-08-08 | Inflow Dynamics, Inc. | Vascular and endoluminal stents with improved coatings |
US5871437A (en) | 1996-12-10 | 1999-02-16 | Inflow Dynamics, Inc. | Radioactive stent for treating blood vessels to prevent restenosis |
US6171232B1 (en) * | 1997-06-26 | 2001-01-09 | Cordis Corporation | Method for targeting in vivo nitric oxide release |
NO311781B1 (en) | 1997-11-13 | 2002-01-28 | Medinol Ltd | Metal multilayer stents |
KR100356643B1 (en) * | 2000-03-31 | 2002-10-18 | 한국과학기술연구원 | Biocompatible Metallic Materials Grafted with Biologically Active Compounds and Preparation Thereof |
-
2000
- 2000-12-26 US US09/681,080 patent/US6398806B1/en not_active Expired - Lifetime
-
2001
- 2001-12-18 EP EP01989249A patent/EP1387704B1/en not_active Expired - Lifetime
- 2001-12-18 AT AT01989249T patent/ATE434453T1/en not_active IP Right Cessation
- 2001-12-18 DE DE60139083T patent/DE60139083D1/en not_active Expired - Lifetime
- 2001-12-18 WO PCT/US2001/049788 patent/WO2003026715A2/en not_active Application Discontinuation
- 2001-12-18 ES ES01989249T patent/ES2329113T3/en not_active Expired - Lifetime
-
2002
- 2002-03-18 US US10/100,765 patent/US20020103530A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6123712A (en) | 1996-08-23 | 2000-09-26 | Scimed Life Systems, Inc. | Balloon catheter with stent securement means |
US5957930A (en) | 1996-09-27 | 1999-09-28 | Scimed Life Systems, Inc. | Stent deployment catheter with midshaft seal |
US5824045A (en) | 1996-10-21 | 1998-10-20 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US6120522A (en) | 1998-08-27 | 2000-09-19 | Scimed Life Systems, Inc. | Self-expanding stent delivery catheter |
Also Published As
Publication number | Publication date |
---|---|
US6398806B1 (en) | 2002-06-04 |
EP1387704A2 (en) | 2004-02-11 |
EP1387704B1 (en) | 2009-06-24 |
US20020103530A1 (en) | 2002-08-01 |
ATE434453T1 (en) | 2009-07-15 |
DE60139083D1 (en) | 2009-08-06 |
ES2329113T3 (en) | 2009-11-23 |
WO2003026715A3 (en) | 2003-12-04 |
US20020082676A1 (en) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6398806B1 (en) | Monolayer modification to gold coated stents to reduce adsorption of protein | |
US5824045A (en) | Vascular and endoluminal stents | |
US6355058B1 (en) | Stent with radiopaque coating consisting of particles in a binder | |
US8333798B2 (en) | Implantable medical devices with enhanced visibility, mechanical properties and biocompatability | |
US7713297B2 (en) | Drug-releasing stent with ceramic-containing layer | |
US8109991B2 (en) | Endoprosthesis having foot extensions | |
US7625398B2 (en) | Endoprosthesis having foot extensions | |
JP4563402B2 (en) | Stent catheter with permanently attached conductor | |
JP2005508671A (en) | Delivery of therapeutically effective drugs | |
EP2429461A1 (en) | Stent | |
US11291569B2 (en) | Monolithic medical devices, methods of making and using the same | |
US20150190555A1 (en) | Methods, Systems, and Devices Relating to Directional Eluting Implantable Medical Devices | |
CA2402046A1 (en) | Selective radiopaque plating of a stent | |
US20120101565A1 (en) | Bioabsorbable stent having radiopacity | |
EP2554140B1 (en) | Stent | |
CA2421797A1 (en) | Selectively etched radiopaque intraluminal device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ PH PL PT RO SD SE SG SI SK SL TJ TM TR TT TZ UG US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE CH CY DE DK FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001989249 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001989249 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |